- CANDID-CNS TM achieves an 83% success rate for predicting small molecule brain penetration and distribution versus a 64% success rate for the industry standard CNS-MPO score - Only ~2% of small ...

This episode of the Pharmaron DMPK Insights Podcast Series sees Scott Summerfield (Senior Director and Head of Pharmaceutical Metabolism at Pharmaron) and Professor Elizabeth de Lange Professor in ...

Founding CEO of Allele Biotech and President of the Scintillon Institute, he is an RNA molecular biologist advancing mRNA-based reprogramming and iPSC engineering. He develops high-potency transient ...

Researchers at the Brigham and Women’s Hospital have developed a technology that rapidly converts stem cells to brain cells with protein structures characteristic of Parkinson’s disease (PD), helping ...